SYK Stryker Corporation

Healthcare

Price

$278.20

Intrinsic value

$105.56

Buy price

$84.45

Discount

-163.5%

Overvalued

Live signals (2)

Daily bars as of Oct 8, 2026

Conflicting signals

FS-BullishFailure Swing (bullish)Bullish ↑
Price undercut a recent swing low and closed back above it - the breakdown failed and trapped the sellers who chased it.
Fired Oct 8, 2026on the latest daily bar37.4% win rate · 1.07x profit factor
DCDowntrend ContinuationBearish ↓
A strong bearish bar rejecting a falling 20/50-SMA stack - the downtrend resuming after a bounce into the moving averages.
Fired Oct 7, 20261 daily bar ago32.9% win rate · 0.89x profit factor

A pattern is reported for 5 bars after it fires (the sweet-spot fill window), so an older bar count means the entry has had longer to play out - not that the signal is stronger. Win rate and profit factor are the pattern's backtested averages across the S&P 500, not a forecast for this ticker.

DCF walkthrough

Near-term growth (g1)10.83%

Terminal growth (g2)3.50%

Years of g1 growth4

Discount rate9.00%

Margin of safety20.00%

Operating CF: $5,525,000,000.00
Total debt: $15,445,999,616.00
Cash & STI: $3,476,000,000.00
Shares out.: 386,000,000

Overvalued

Intrinsic value$105.57

Buy price (with MOS)$84.45

Current price$278.20

Discount to intrinsic value-163.5%

7-step quality scorecard

ROE quality

HIGH_CONSISTENT

Average ROE: 15.0%
Current ROE: 14.5%
Minimum ROE: 14.2%

Debt quality

MODERATE

Debt / Equity: 0.69x

Moat proxy

STRONG_PROXY

Cash-flow reliability

Operating CF / Net income: 1.48x

Technical chart

Confluence: DOWNTREND (0/3)

Weekly candles, ~3 years. Yellow line: 10-week EMA. Dashed lines: Fibonacci retracement of the last 52-week swing. Green arrow: an active DR1 support reclaim (see Live signals above for when it fired).

Assumptions & data quality

Data source: yfinance
Growth (g1) source: min(revenueCAGR,cfCAGR)
Valuation model: DCF_OCF
Debt as % of DCF PV: 29.3%
Public economic interest: 100.0%

These are model outputs built on assumptions (growth rate, discount rate, margin of safety), not facts - trust but verify, especially for LOW cash-flow-reliability or UNKNOWN-quality rows.